ロード中...
Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor
Previous studies suggest that diabetes impairs hematopoietic stem cell (HSC) mobilization in response to granulocyte colony-stimulating factor (G-CSF). In this study, we tested whether the CXCR4 antagonist plerixafor, differently from G-CSF, is effective in mobilizing HSCs in patients with diabetes....
保存先:
| 出版年: | Diabetes |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Diabetes Association
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4512229/ https://ncbi.nlm.nih.gov/pubmed/25804941 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db15-0077 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|